Inhibition of specific effector T cell-target cell conjugates by cell plasma membranes
Gilmer, P.J.; McDevitt, H.O.; McConnell, H.M.
Journal of Immunology 120(3): 774-776
1978
ISSN/ISBN: 0022-1767 PMID: 305445 Document Number: 135813
Conjugate formation between effector T cells raised in vivo in a BALB/c hose had fluorescein diacetate-labeled allogeneic EL4 tumor target cells was observed and scored by using a fluorescence mirroscope. This conjugate formation was found to be specifically inhibited by plasma membrane vesicles isolated from the EL4 cells.
Document emailed within 1 workday
Related Documents
Bradley, T.P.; Bonavida, B. 1982: Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay Journal of Immunology 129(5): 2260-2265Blazar, B.A.; Fitzgerald, J.; Sutton, L.; Strome, M. 1983: Increased sensitivity to natural killing in Raji cells is due to effector recognition of molecules appearing on target cell membranes following EBV cycle induction Clinical and Experimental Immunology 54(1): 31-38
Berman, J.E.; Zolla-Pazner, S. 1985: Control of B cell proliferation: inhibition of responses to B cell mitogens induced by plasma cell tumors Journal of Immunology 134(5): 2872-2878
Sentman, C.L.; Olsson-Alheim, M.Y.; Lendahl, U.; Kärre, K. 1996: H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene Journal of Immunology 156(7): 2423-2429
Lee, N.P.Y.; Cheng, C.Y. 2004: Ectoplasmic specialization, a testis-specific cell-cell actin-based adherens junction type: is this a potential target for male contraceptive development? Human Reproduction Update 10(4): 349-369
Kornstein, M.J.; deBlois, G.G.; Williams, M.E. 1992: Unusual biclonal plasma cell dyscrasia with crystallike inclusions producing colonic tumors (plasma cell polyposis) and terminating in T-cell lymphoma Archives of Pathology and Laboratory Medicine 116(2): 168-172
Zarling, J.M.; Dierckins, M.S.; Sevenich, E.A.; Clouse, K.A. 1981: Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations Journal of Immunology 127(5): 2118-2123
Beezer, A.E.; Navratil, J.; Fiserova, A.; Pospisil, M. 1993: Different immunomodulator regulated patterns of effector-target cell interactions: a novel application of microcalorimetry Microbios 73(296): 205-213
Fan, J.; Bonavida, B. 1981: Studies on the induction and expression of T cell-mediated immunity. XII. The concomitant loss and recovery of membrane-associated Lyt-2 antigens, lymphocyte-target cell binding, and the antigen-specific and -nonspecific cytotoxic activity of alloimmune T lymphocytes after treatment with trypsin Journal of Immunology 127(5): 1856-1864
Scornik, J.C. 1974: Antibody-dependent cell-mediated cytotoxicity. II. Early interactions between effector and target cells Journal of Immunology 113(5): 1519-1526
Krahenbuhl, J.L.; Remington, J.S. 1977: Inhibition of target cell mitosis as a measure of the cytostatic effects of activated macrophages on tumor target cells Cancer Research 37(11): 3912-3916
Santoli, D.; Trinchieri, G.; Lief, F.S. 1978: Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte Journal of Immunology 121(2): 526-531
Hoffeld, J.T.; Marrack, P.; Kappler, J.W. 1976: Antigen-specific and nonspecific mediators of T cell/B cell cooperation. V. Unresponsiveness to HGG in vitro of these two T cell subpopulations Journal of Immunology 117(5 Pt.2): 1960-1965
Holden, H.T.; Oldham, R.K.; Ortaldo, J.R.; Herberman, R.B. 1977: Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells Journal of the National Cancer Institute 58(3): 611-622
Dennert, G. 1974: Effector mechanisms of cell-mediated immunity to xenogeneic cell antigens Journal of Immunology 113(1): 201-208
Kurabe, N.; Arai, S.; Miyazaki, T. 2009: Cell cycle and cell sizing regulation via death effector domain Seikagaku. Journal of Japanese Biochemical Society 81(1): 24-27
South, M.A. 1978: The "M" cell. a special effector cell system for rejection of hematopoietic grafts Cutis 22(1): 34; 39
Commes, T.; Clofent, G.; Ghanem, N.; Zhang, X.G.; Lefranc, M.P.; Bataille, R.; Klein, B. 1993: Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines Leukemia 7(4): 609-617
Takekawa, F.; Nagumo, T.; Shintani, S.; Hashimoto, K.; Kikuchi, H.; Katayama, T.; Ishihara, M.; Amano, O.; Kawase, M.; Sakagami, H. 2007: Tumor-specific cytotoxic activity and type of cell death induced by 4-trifluoromethylimidazoles in human oral squamous cell carcinoma cell lines Anticancer Research 27(6b): 4065-4069
Dupont, E.; Opelz, G.; Gustafsson, L.A.; Mikulski, S.M.; Terasaki, P.I. 1977: Depressed effector cell function in antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients Transplantation 23(2): 165-168